We asked Dr. Joanne Pike, CEO of the Alzheimer's Association to help explain the challenges and hopes when it comes to this ...

A preprint research letter linking the Alzheimer's drug lecanemab (Leqembi) with excess deaths was withdrawn last week. The ...

A study of cells from 84 cadaver brains suggests that Alzheimer’s has two distinct phases, and that one type of neuron is ...

An 80-something patient came in for an annual visit recently and was worried that recent memory lapses might be symptoms of ...

Police are asking for help finding a missing U.S. Army veteran who suffers from Alzheimer's disease and dementia.Park Forest ...

A 72-year-old man from Youngstown, Ohio, has now completed a more than 2,200 mile fundraising bike ride across the country to ...

The Fighting the Good Fight to End Alzheimer’s event is set for Saturday at First United Presbyterian Church in Mingo ...

Are veterans more prone to Alzheimer’s disease? According to the U.S. Department of Veterans Affairs, veterans are more ...

Research involving the UAB reveals the most effective way to talk to people with Alzheimer's so that their emotional response ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

Dr Charles Vega believes that primary care will be the chief clinical setting for application of new blood-based biomarkers.

The Bridge Alzheimer’s & Dementia Resource Center is a 501(c)3 non-profit organization. All funds raised by the organization ...